IL10 and inflammatory bowel disease: Indeed, mutations in Il10 or Il10R result in severe early-onset forms of IBD (Glocker et al., 2009, Kotlarz et al., 2012, Uhlig et al., 2014), indicating that IL-10 signaling is critical to prevent colitis both in humans and in mice.